- 320. Lane NE, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W, Hochberg MC: OARSI- FDA initiative: Defining the disease state of osteoarthritis. Osteoarthritis Cart 2011;19:478-82. Epub 2011 Mar 23.
- 321. Oyen J, Rohde G, Hochberg M, Johnsen V, Haugeberg G: Low bone mineral density is a significant risk factor for low-energy distal radius fractures in middle-aged and elderly men: a case-control study. BMC Musculoskeletal Disorders 2011 Apr 2;12:67.
- 322. D'Adamo CR, Shardell MD, Hicks GE, Orwig DL, Hochberg MC, Semba RD, Yu - Yahiro JA, Ferrucci L, Magaziner JS, Miller RR: Serum vitamin E concentrations among highly functioning hip fracture patients are higher than in nonfracture controls. Nutr Res 2011;31:205-14.
- 323. D'Adamo CR, Miller RR, Hicks GE, Orwig DL, Hochberg MC, Semba RD, Yu -Yahiro JA, Ferrucci L, Magaziner J, Shardell MD: Serum vitamin E concentrations and recovery of physical function during the year after hip fracture. J Gerontol A Biol Sci Med Sci 2011;66:784-93. Epub 2011 Apr 12.
- 324. Hochberg MC, Fort JG, Svensson O, Hwang C, Sostek M: Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials. Curr Med Res Opin 2011;27:1243-53. Epub 2011 Apr 28.
- 325. Adler RA, Hochberg MC: Glucocorticoid-induced osteoporosis in men. J Endocrinol Invest 2011;34:481-4. Epub May 27.
- 326. Eaton CB, Hochberg MC, Assaf A, Cryer BL, Lu B, Sands G, rodriguez B, Lacroix A, Lessin L, Limacher MC, Fugate Woods N, Connelly S, Chen Z: The cross-sectional relationship of hemoglobin levels and functional outcomes in women with self-reported osteoarthritis: R esults from the Women's Health Initiative . Semin Arthritis Rheum 2011;41:406-14. Epub 2011 July 2.
- 327. Dunlop DD, Song J, Semanik PA, chang RW, Sharma L, Bathon JM, eaton CB, Hochberg MC, Jackson RD, Kwoh KC, Mysiw WJ, Nevitt MC, Hootman JM: Objective physical activity measurement in the osteoarthritis initiative: are guidelines being met? Arthritis Rheum 2011;63:3372-82.
- 328. 328. Gossec L, Paternotte S, Bingham CO 3 , Clegg DO, Coste P, Conaghan PG, et al, for the OARSI-OMERACT Task Force: OARSI/OMERACT Initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis: an OMERACT 10 Special Interest Group. J Rheumatol 2011;38:1765-9.
- 329. Alley DE, Hicks GE, Shardell M, Hawkes W, Miller R, Craik RL, Mangione KK, Orwig D, Hochberg M, Resnick B, Magaziner J: Meaningful improvement in gait speed in hip fracture recovery. J AmGeriatr Soc 2011;59:1650-7. Epub 2011 Aug 24.
- 330. Diamantopoulos AP, Rohde G, Johnsrud I, Skoie IM, Johnsen V, Hochberg M, Haugeberg G: Incidence rates of fragility hip fracture in middle-aged and elderly men and women in Southern Norway. Age Aging 2012;41:86-92. Epub 2011 Sept 6.
- 331. Bell KJ, Hayen A, Irwig L, Hochberg MC, Ensrud KE, Cummings S, Bauer DC: The potential value of monitoring bone turnover markers among women on alendronate. J Bone Miner Res 2011 Sep 28. [Epub ahead of print]
- 332. Frakes E, Risser R, Ball T, Hochberg M, Wohlreich M: Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin 2011;27:2361-72. Epub 2011 Nov 9.